Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC

SolicitationNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in VANCOUVER, WA
  • Industry: In-Vitro Diagnostic Substance Manufacturing

Contract Details

Notice ID
36C26026Q0960
Opportunity Type
Solicitation
Sub-Agency
VETERANS AFFAIRS, DEPARTMENT OF
Office
260-NETWORK CONTRACT OFFICE 20 (36C260)
Posted Date
Wednesday, August 19, 2026
Response Deadline
Thursday, September 10, 2026
PSC Code
6515
Set-Aside
No Set Aside
Place of Performance
VANCOUVER, WA, 98661
Status
Active

Description

Our scope is to acquire specific FDA-approved infectious disease and oncology assays formulated as single-use test cartridges and reagents that are equal to and/or compatible to what is currently being used on the VA owned instrument/analyzer. Required rapid molecular assays include targets for C. difficile, SARS-CoV-2 with Influenza A & B and RSV, Strep A, MTB IVD Mycobacterium tuberculosis with Rif, MVP-Multiplex Vaginal Panel, GI Panel, MRSA Carba-R, Norovirus, BCR-ABL, FII & FV and vanA PCR. The kit storage temperature should be 2 28C and not require refrigeration. Time and date of delivery to be determined by the PSHCS Microbiology Department.

Why This Opportunity Matters

VETERANS AFFAIRS, DEPARTMENT OF is actively seeking qualified contractors for in-vitro diagnostic substance manufacturing with a set-aside for No Set Aside businesses in VANCOUVER, WA. This set-aside designation means eligible businesses face reduced competition from larger firms.